EQS Preliminary announcement financial reports: PAION AG / Preliminary announcement on the disclosure of financial statements
PAION AG: Preliminary announcement of the publication of. | May 15, 2023
EQS-Ad-hoc: PAION AG / Key word: Regulatory Approval
PAION receives European Commission approval of remimazolam for the Induction and maintenance of general anesthesia in adults
03-Apr-2023 /. | April 3, 2023
EQS-News: PAION AG / Key word: Miscellaneous
PAION AG implements resolved capital reduction
31.03.2023 / 19:15 CET/CEST
The issuer is solely responsible for the content of this. | March 31, 2023
EQS-News: PAION AG / Key word: Annual Results
PAION AG reports on fiscal year 2022
30.03.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this. | March 30, 2023